GenMont Biotech Incorporation (TPE:3164)

TPE:3164 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	391.48	385.37	318.02	368.55	427.93	325.19
Revenue Growth (YoY)	6.23%	21.18%	-13.71%	-13.88%	31.59%	-6.08%
Cost of Revenue	155.7	147.19	106.82	111.83	128.6	109.8
Gross Profit	235.77	238.18	211.19	256.72	299.33	215.39
Selling, General & Admin	148.14	152.79	156.6	137.12	145.47	118.73
Research & Development	44.66	45.27	46.86	59.41	25.52	26.3
Operating Expenses	191.83	197.55	204.2	194.75	174.29	144.42
Operating Income	43.94	40.63	6.99	61.97	125.04	70.97
Interest Expense	-4.09	-3.72	-0.97	-0.76	-0.77	-0.81
Interest & Investment Income	8.64	11.6	9.46	4.8	2.35	2.89
Earnings From Equity Investments	-	-	-	-	-	-0.1
Currency Exchange Gain (Loss)	-17.31	17.05	-6.98	10.45	-1.35	-1.34
Other Non Operating Income (Expenses)	1.08	0.4	0.34	-1.98	1.06	0.82
EBT Excluding Unusual Items	32.27	65.97	8.83	74.48	126.34	72.44
Gain (Loss) on Sale of Investments	3.48	-1.23	19.05	-8.16	9.35	-3.32
Gain (Loss) on Sale of Assets	-0.02	-0.02	0.28	-0.06	3.74	0.24
Other Unusual Items	-	-	-	-	-	7.49
Pretax Income	35.73	64.72	28.16	66.26	139.42	76.85
Income Tax Expense	10.23	16.97	5.73	18.8	29.82	16.63
Earnings From Continuing Operations	25.49	47.75	22.43	47.46	109.6	60.22
Net Income to Company	25.49	47.75	22.43	47.46	109.6	60.22
Minority Interest in Earnings	9	9.5	10.56	9.52	3.53	0.67
Net Income	34.49	57.25	32.99	56.98	113.13	60.88
Net Income to Common	34.49	57.25	32.99	56.98	113.13	60.88
Net Income Growth	-35.10%	73.53%	-42.10%	-49.64%	85.82%	5.98%
Shares Outstanding (Basic)	86	87	86	86	86	88
Shares Outstanding (Diluted)	87	87	87	87	87	88
Shares Change (YoY)	-0.09%	0.18%	-0.10%	-0.09%	-1.50%	-1.34%
EPS (Basic)	0.40	0.66	0.38	0.66	1.31	0.69
EPS (Diluted)	0.39	0.66	0.38	0.66	1.30	0.69
EPS Growth	-36.53%	73.68%	-42.40%	-49.25%	88.41%	7.81%
Free Cash Flow	89.49	79.89	1.29	65.79	-5.28	-20.5
Free Cash Flow Per Share	1.03	0.92	0.01	0.76	-0.06	-0.23
Dividend Per Share	0.800	0.800	0.500	0.700	1.100	0.700
Dividend Growth	60.00%	60.00%	-28.57%	-36.36%	57.14%	-12.50%
Gross Margin	60.23%	61.80%	66.41%	69.66%	69.95%	66.23%
Operating Margin	11.22%	10.54%	2.20%	16.81%	29.22%	21.82%
Profit Margin	8.81%	14.86%	10.37%	15.46%	26.44%	18.72%
Free Cash Flow Margin	22.86%	20.73%	0.41%	17.85%	-1.23%	-6.30%
EBITDA	107.55	108.18	68.77	109.92	143.05	88.77
EBITDA Margin	27.47%	28.07%	21.63%	29.82%	33.43%	27.30%
D&A For EBITDA	63.61	67.55	61.79	47.95	18.02	17.8
EBIT	43.94	40.63	6.99	61.97	125.04	70.97
EBIT Margin	11.22%	10.54%	2.20%	16.81%	29.22%	21.82%
Effective Tax Rate	28.64%	26.22%	20.35%	28.37%	21.39%	21.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.